Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
a patient was given Boostrix into the gluteal muscle on Friday; This non-serious case was reported by a nurse via call center representative and described the occurrence of vaccine administered at inappropriate site in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 08-AUG-2025, the patient received Boostrix (unknown gluteal). On 08-AUG-2025, an unknown time after receiving Boostrix, the patient experienced vaccine administered at inappropriate site (Verbatim: a patient was given Boostrix into the gluteal muscle on Friday). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 11-AUG-2025 Nurse reported that a patient was given Boostrix into the gluteal muscle on Friday which led to vaccine administered at inappropriate site. No patient or product details were available. The reporter did not have details regarding product so unsure of presentation.